Candel Therapeutics, Inc. (CADL) vs Immix Biopharma, Inc. (IMMX)

Candel Therapeutics, Inc. and Immix Biopharma, Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and Immix Biopharma, Inc. are of similar size ($883.8M and $844.3M). Across the 9 metrics below, Immix Biopharma, Inc. leads on 7 and Candel Therapeutics, Inc. on 2.

Valuation

Metric CADL IMMX Biotechnology median
P/E n/m n/m 7.88
P/S 6,535.41 n/m 11.47
P/B 6.48 3.07 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 5,339.33 n/m 10.73
Earnings yield (12.79%) (7.98%) (28.84%)
Free cash flow yield (7.01%) (5.56%) (23.03%)

Profitability

Metric CADL IMMX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (81.84%) (34.18%) (57.72%)
Return on assets (56.37%) (31.34%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CADL IMMX Biotechnology median
Revenue growth (TTM) 0.00% — 5.64%
EPS growth (last fiscal year) 58.62% (17.11%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CADL IMMX Biotechnology median
Debt to equity 0.38 0.00 0.00
Current ratio 16.09 25.13 4.73
Net debt to EBITDA 1.53 3.39 0.96

Dividend

Metric CADL IMMX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CADL IMMX Biotechnology median
Market cap 883.79m 844.32m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack